Anti-Müllerian Hormone is Not Predictive of Pregnancy in Donor Insemination Cycles in Non-infertile Women

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

143 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-01

Study Completion Date

2016-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate if ovarian reserve (measured by means of anti-mullerian hormone -AMH- and antral follicle count -AFC-) can predict pregnancy in donor insemination cycles (dIUI) performed in non-infertile women.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response

NCT04168892

Ovarian Response

COMPLETED

Antimullerian Hormone as an Indicator for Ovarian Response

NCT03291860

Infertility, Female

UNKNOWN

Pregnancy Prediction Using Anti-Müllerian Hormone in Intrauterine Insemination Cycles

NCT06263192

Infertility, Female Anti-Mullerian Hormone Deficiency

COMPLETED

Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins

NCT02237781

Female Infertility

UNKNOWN PHASE2/PHASE3

AMH and Pregnancy Outcome in IVF

NCT04512807

AMH

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women who undergo donor sperm insemination

Non infertile women who undergo donor sperm insemination cycle

Anti Mullerian Hormone Measurement

Intervention Type DIAGNOSTIC_TEST

Anti Mullerian Hormone was measured in all patients within two months before the first insemination cycle

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anti Mullerian Hormone Measurement

Anti Mullerian Hormone was measured in all patients within two months before the first insemination cycle

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* absence of male partner
* complete azoospermia or the presence of a genetic condition in the partner that made the couple opt for donor sperm
* absence of previous history of infertility.
* d ta on AMH and AFC assessment before the first dIUI cycle.

Exclusion Criteria

* previous history of infertility.
* Presence of any gynaecological condition that could impair the inseminations results:

* endometriosis, hydrosalpinx,…

Minimum Eligible Age

18 Years

Maximum Eligible Age

43 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No